Brief: Maxcyte Announces Preliminary Unaudited Fourth Quarter And Full Year 2025 Financial Results
12/01/2026 13:15
Jan 12 (Reuters) - MaxCyte Inc MXCT.O: MAXCYTE ANNOUNCES PRELIMINARY UNAUDITED FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS Q4 CORE REVENUE EXPECTED BETWEEN $6.6 MILLION AND $6.7 MILLION Q4 REVENUE VIEW $9.4 MILLION -- LSEG IBES DATA Source text: ID:nGNX3CB3ZM Further company coverage: MXCT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on MaxCyte
See all newsCell-engineering firm MaxCyte's Q3 revenue beats; annual outlook lifted
Brief: MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
MaxCyte Inc reports results for the quarter ended June 30 - Earnings Summary
MaxCyte Q2 revenue beats estimates
MaxCyte Inc expected to post a loss of 9 cents a share - Earnings Preview